No retraction, correction or concern found when last checked on Nov 1, 2026.

Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies

Puneeta Tandon, Guadalupe Garcia‐Tsao

Liver International · 2009 · Systematic review

doi:10.1111/j.1478-3231.2008.01957.x

Abstract

Background: Although there are many studies of the predictors of death in hepatocellular carcinoma (HCC), most combine patients with and without cirrhosis and many combine those with compensated and decompensated cirrhosis. Objective: To perform a systematic review of the literature evaluating the predictors of death in patients with cirrhosis and HCC and to evaluate whether the predictors differ between patients with compensated and decompensated cirrhosis. Methods: Inclusion criteria: (i) publication in English, (ii) adult patients, (c) >80% of the patients had cirrhosis, (iv) follow‐up >6 months and (v) multivariable analysis. Quality was based on the accepted quality criteria for prognostic studies. Results: Of the 1106 references obtained, 947 were excluded because they did not meet the inclusion criteria. A total of 23 968 patients were included in 72 studies (median, 177/study); 77% male, median age 64, 55% Child–Pugh class A. The most robust predictors of death were portal vein thrombosis, tumour size, α‐foetoprotein and Child–Pugh class. Sensitivity analysis using only 15 ‘good’ studies and 22 studies in which all patients had cirrhosis yielded the same variables. In the studies including mostly compensated or decompensated patients, the predictors were both liver and tumour related. However, these studies were few and the results were not robust. Conclusions: This systematic review of 72 studies shows that the most robust predictors of death in patients with cirrhosis and HCC are tumour related and liver related. Future prognostic studies should include these predictors and should be performed in specific patient populations to determine whether specific prognostic indicators are more relevant at different stages of cirrhosis.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 89

1.
Fattovich G, Giustina G, Degos F, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology. 1997;112:463-72.
Not in our library10.1053/gast.1997.v112.pm9024300
2.
D'Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217-31.
Not in our library10.1016/j.jhep.2005.10.013
3.
Okuda K, Ohtsuki T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer. 1985;56:918-2.
Not in our library10.1002/1097-0142(19850815)56:4<918::aid-cncr2820560437>3.0.co;2-e
4.
A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology. 1998;28:751-5.
Not in our library10.1002/hep.510280322
5.
Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19:329-38.
Not in our library10.1055/s-2007-1007122
6.
Diamond GA. Future imperfect: the limitations of clinical prediction models and the limits of clinical prediction. J Am Coll Cardiol. 1989;14(Suppl. A):12A-22A.
Not in our library10.1016/0735-1097(89)90157-5
7.
Laupacis A, Sekar N, Stiell IG. Clinical prediction rules. A review and suggested modifications of methodological standards. JAMA. 1997;277:488-94.
Not in our library
8.
Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Ann Intern Med. 1999;130:515-24.
Not in our library10.7326/0003-4819-130-6-199903160-00016
9.
Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693-9.
Not in our library10.1056/nejm199603143341104
10.
Calvet X, Bruix J, Gines P, et al. Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients. Hepatology. 1990;12(Part 1):753-60.
Not in our library10.1002/hep.1840120422
11.
Akashi Y, Koreeda C, Enomoto S, et al. Prognosis of unresectable hepatocellular carcinoma: an evaluation based on multivariate analysis of 90 cases. Hepatology. 1991;14:262-8.
Not in our library
12.
Barbara L, Benzi G, Gaiani S, et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology. 1992;16:132-7.
Not in our library10.1002/hep.1840160122
13.
Nomura F, Ohnishi K, Honda M, et al. Clinical features of hepatocellular carcinoma in the elderly: a study of 91 patients older than 70 years. Br J Cancer. 1994;70:690-3.
Not in our library10.1038/bjc.1994.374
14.
Pirisi M, Fabris C, Soardo G, et al. Prognostic value of serum alpha-1-antitrypsin in hepatocellular carcinoma. Eur J Cancer. 1996;32A:221-5.
Not in our library10.1016/0959-8049(95)00542-0
15.
Yamashita F, Tanaka M, Satomura S, Tanikawa K. Prognostic significance of Lens culinaris agglutinin A-reactive alpha-fetoprotein in small hepatocellular carcinomas. Gastroenterology. 1996;111:996-1001.
Not in our library10.1016/s0016-5085(96)70067-7
16.
Kouroumalis EA, Skordilis PG, Moschandrea J, et al. Natural history of advanced hepatocellular carcinoma in Crete. Association with hepatitis C virus. Eur J Gastroenterol Hepatol. 1997;9:981-8.
Not in our library10.1097/00042737-199710000-00011
17.
Shiota G, Kishimoto Y, Suyama A, et al. Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma. J Hepatol. 1997;27:661-8.
Not in our library10.1016/s0168-8278(97)80083-9
18.
Tanizaki H, Ryu M, Kinoshita T, et al. Comparison of clinical features and survival in patients with hepatitis B and C virus-related hepatocellular carcinoma. Jpn J Clin Oncol. 1997;27:67-70.
Not in our library10.1093/jjco/27.2.67
19.
Ebara M, Hatano R, Fukuda H, et al. Natural course of small hepatocellular carcinoma with underlying cirrhosis. A study of 30 patients. Hepatogastroenterology. 1998;45(Suppl. 3):1214-20.
Not in our library
20.
Pawarode A, Voravud N, Sriuranpong V, Kullavanijaya P, Patt YZ. Natural history of untreated primary hepatocellular carcinoma: a retrospective study of 157 patients. Am J Clin Oncol. 1998;21:386-91.
Not in our library10.1097/00000421-199808000-00014
21.
Chevret S, Trinchet JC, Mathieu D, et al. A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. J Hepatol. 1999;31:133-41.
Not in our library10.1016/s0168-8278(99)80173-1
22.
Hayashi K, Kumada T, Nakano S, et al. Usefulness of measurement of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein as a marker of prognosis and recurrence of small hepatocellular carcinoma. Am J Gastroenterol. 1999;94:3028-33.
Not in our library10.1111/j.1572-0241.1999.01378.x
23.
Llovet JM, Bustamante J, Castells A, et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology. 1999;29:62-7.
Not in our library10.1002/hep.510290145
24.
Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. The Cancer of the Liver Italian Program (CLIP) Investigators. Hepatology. 2000;31:840-5.
Not in our library10.1053/he.2000.5628
25.
Dohmen K, Shirahama M, Onohara S, et al. Differences in survival based on the type of follow-up for the detection of hepatocellular carcinoma: an analysis of 547 patients. Hepatol Res. 2000;18:110-21.
Not in our library10.1016/s1386-6346(99)00094-7
26.
Farinati F, Rinaldi M, Gianni S, Naccarato R. How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system. Cancer. 2000;89:2266-73.
Not in our library
27.
Giannini E, Arzani L, Borro P, et al. Does surveillance for hepatocellular carcinoma in HCV cirrhotic patients improve treatment outcome mainly due to better clinical status at diagnosis? Hepatogastroenterology. 2000;47:1395-8.
Not in our library
28.
Tangkijvanich P, Janchai A, Charuruks N, et al. Clinical associations and prognostic significance of serum anti-p53 antibodies in Thai patients with hepatocellular carcinoma. Asian Pac J Allergy Immunol. 2000;18:237-43.
Not in our library
29.
Farinati F, Gianni S, Marin G, et al. Does the choice of treatment influence survival of patients with small hepatocellular carcinoma in compensated cirrhosis? Eur J Gastroenterol Hepatol. 2001;13:1217-24.
Not in our library10.1097/00042737-200110000-00015
30.
Lerose R, Molinari R, Rocchi E, Manenti F, Villa E. Prognostic features and survival of hepatocellular carcinoma in Italy: impact of stage of disease. Eur J Cancer. 2001;37:239-45.
Not in our library10.1016/s0959-8049(00)00354-3
31.
Schoniger-Hekele M, Muller C, Kutilek M, et al. Hepatocellular carcinoma in Central Europe: prognostic features and survival. Gut. 2001;48:103-9.
Not in our library10.1136/gut.48.1.103
32.
Shiomi S, Nishiguchi S, Ishizu H, et al. Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma. Am J Gastroenterol. 2001;96:1877-80.
Not in our library10.1111/j.1572-0241.2001.03888.x
33.
Toyoda H, Kumada T, Nakano S, et al. Impact of diabetes mellitus on the prognosis of patients with hepatocellular carcinoma. Cancer. 2001;91:957-63.
Not in our library
34.
Ueno S, Tanabe G, Sako K, et al. Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program. Hepatology. 2001;34:529-34.
Not in our library10.1053/jhep.2001.27219
35.
Giannelli G, Pierri F, Trerotoli P, et al. Occurrence of portal vein tumor thrombus in hepatocellular carcinoma affects prognosis and survival. A retrospective clinical study of 150 cases. Hepatol Res. 2002;24:50.
Not in our library10.1016/s1386-6346(02)00027-x
36.
Giannini E, Romagnoli P, Fasoli A, et al. Influence of age on clinical presentation, therapeutic options, and prognosis in anti-HCV positive cirrhotic patients with hepatocellular carcinoma. Age Ageing. 2002;31:457-62.
Not in our library10.1093/ageing/31.6.457
37.
Ohkubo K, Kato Y, Ichikawa T, et al. Viral load is a significant prognostic factor for hepatitis B virus-associated hepatocellular carcinoma. Cancer. 2002;94:2663-8.
Not in our library10.1002/cncr.10557
38.
Ueno S, Tanabe G, Nuruki K, et al. Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center. J Hepato Pancreat Surg. 2002;9:469-77.
Not in our library10.1007/s005340200058
39.
Kawakita T, Shiraki K, Yamanaka Y, et al. A new prognostic scoring system involving des-gamma-carboxy prothrombin as a useful marker for predicting prognosis in patients with hepatocellular carcinoma. Int J Oncol. 2003;23:1115-20.
Not in our library
40.
Nagaoka S, Yatsuhashi H, Hamada H, et al. The des-gamma-carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma. Cancer. 2003;98:2671-7.
Not in our library10.1002/cncr.11839
41.
Tan CK, Law NM, Ng HS, Machin D. Simple clinical prognostic model for hepatocellular carcinoma in developing countries and its validation. J Clin Oncol. 2003;21:2294-8.
Not in our library10.1200/jco.2003.03.151
42.
Yano Y, Yamashita F, Sumie S, et al. Clinical significance of antibody against hepatitis B virus core antigen in patients with hepatitis C virus-related hepatocellular carcinoma. Liver Int. 2003;23:227-31.
Not in our library10.1034/j.1600-0676.2003.00831.x
43.
Akamatsu M, Yoshida H, Shiina S, et al. Neither hepatitis C virus genotype nor virus load affects survival of patients with hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2004;16:459-66.
Not in our library10.1097/00042737-200405000-00004
44.
Trevisani F, Cantarini MC, Labate AM, et al. Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival. Am J Gastroenterol. 2004;99:1470-6.
Not in our library10.1111/j.1572-0241.2004.30137.x
45.
Cillo U, Bassanello M, Vitale A, et al. The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? J Hepatol. 2004;40:124-31.
Not in our library10.1016/j.jhep.2003.09.027
46.
Dohmen K, Shirahama M, Shigematsu H, Irie K, Ishibashi H. Optimal treatment strategy for elderly patients with hepatocellular carcinoma. J Gastroenterol Hepatol. 2004;19:859-65.
Not in our library10.1111/j.1440-1746.2003.03306.x
47.
Giannini E, Risso D, Botta F, et al. Prognosis of hepatocellular carcinoma in anti-HCV positive cirrhotic patients: a single-centre comparison amongst four different staging systems. J Intern Med. 2004;255:399-408.
Not in our library10.1046/j.1365-2796.2003.01284.x
48.
Kudo M, Chung H, Haji S, et al. Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score. Hepatology. 2004;40:1396-405.
Not in our library10.1002/hep.20486
49.
Lang BH, Poon RT, Fan ST, Wong J. Outcomes of patients with hepatocellular carcinoma presenting with variceal bleeding. Am J Gastroenterol. 2004;99:2158-65.
Not in our library10.1111/j.1572-0241.2004.40336.x
50.
Okumoto K, Hattori E, Tamura K, et al. Possible contribution of circulating transforming growth factor-beta1 to immunity and prognosis in unresectable hepatocellular carcinoma. Liver Int. 2004;24:21-8.
Not in our library10.1111/j.1478-3231.2004.00882.x
51.
Omagari K, Honda S, Kadokawa Y, et al. Preliminary analysis of a newly proposed prognostic scoring system (SLiDe score) for hepatocellular carcinoma. J Gastroenterol Hepatol. 2004;19:805-11.
Not in our library10.1111/j.1440-1746.2004.03350.x
52.
Sakar B, Ustuner Z, Karagol H, et al. Prognostic features and survival of inoperable hepatocellular carcinoma in Turkish patients with cirrhosis. Am J Clin Oncol. 2004;27:489-93.
Not in our library10.1097/01.coc.0000136019.94333.09
53.
Sangiovanni A, Del Ninno E, Fasani P, et al. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. Gastroenterology. 2004;126:1005-14.
Not in our library10.1053/j.gastro.2003.12.049
54.
Siddique I, El-Naga HA, Memon A, et al. CLIP score as a prognostic indicator for hepatocellular carcinoma: experience with patients in the Middle East. Eur J Gastroenterol Hepatol. 2004;16:675-80.
Not in our library10.1097/01.meg.0000108338.41221.ec
55.
Tangkijvanich P, Mahachai V, Suwangool P, Poovorawan Y. Gender difference in clinicopathologic features and survival of patients with hepatocellular carcinoma. World J Gastroenterol. 2004;10:1547-50.
Not in our library10.3748/wjg.v10.i11.1547
56.
Toyoda H, Kumada T, Kiriyama S, et al. Changes in the characteristics and survival rate of hepatocellular carcinoma from 1976 to 2000: analysis of 1365 patients in a single institution in Japan. Cancer. 2004;100:2415-21.
Not in our library10.1002/cncr.20289
57.
Vejchapipat P, Tangkijvanich P, Theamboonlers A, et al. Association between serum hepatocyte growth factor and survival in untreated hepatocellular carcinoma. J Gastroenterol. 2004;39:1182-8.
Not in our library10.1007/s00535-004-1469-8
58.
Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients · 2005
No notice
59.
Grieco A, Pompili M, Caminiti G, et al. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. Gut. 2005;54:411-8.
Not in our library10.1136/gut.2004.048124
60.
Kemp W, Pianko S, Nguyen S, Bailey MJ, Roberts SK. Survival in hepatocellular carcinoma: impact of screening and etiology of liver disease. J Gastroenterol Hepatol. 2005;20:873-81.
Not in our library10.1111/j.1440-1746.2005.03844.x
61.
Marrero JA, Fontana RJ, Barrat A, et al. Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatology. 2005;41:707-16.
Not in our library10.1002/hep.20636
62.
Toyoda H, Kumada T, Kiriyama S, et al. Impact of tumor factors on the prognosis of patients with advanced cirrhosis (Child–Pugh class C) and hepatocellular carcinoma. J Gastroenterol Hepatol. 2005;20:963-5.
Not in our library10.1111/j.1440-1746.2005.03841.x
63.
Toyoda H, Kumada T, Kiriyama S, et al. Comparison of the usefulness of three staging systems for hepatocellular carcinoma (CLIP, BCLC, and JIS) in Japan. Am J Gastroenterol. 2005;100:1764-71.
Not in our library10.1111/j.1572-0241.2005.41943.x
64.
Van Vlierberghe H, Colle I, Henrion J, et al. The HepCar registry: report on a one-year registration program of hepatocellular carcinoma (HCC) in Belgium. What is daily practice in HCC? Acta Gastroenterol Belg. 2005;68:403-11.
Not in our library
65.
Yeung YP, Lo CM, Liu CL, et al. Natural history of untreated nonsurgical hepatocellular carcinoma. Am J Gastroenterol. 2005;100:1995-2004.
Not in our library10.1111/j.1572-0241.2005.00229.x
66.
Cantarini MC, Trevisani F, Morselli-Labate AM, et al. Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma. Am J Gastroenterol. 2006;101:91-8.
Not in our library10.1111/j.1572-0241.2006.00364.x
67.
Cillo U, Vitale A, Grigoletto F, et al. Prospective validation of the Barcelona Clinic Liver Cancer staging system. J Hepatol. 2006;44:723-31.
Not in our library10.1016/j.jhep.2005.12.015
68.
Giannini EG, Risso D, Testa R, et al. Prevalence and prognostic significance of the presence of esophageal varices in patients with hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2006;4:1378-84.
Not in our library10.1016/j.cgh.2006.08.011
69.
Huo TI, Lin HC, Huang YH, et al. The model for end-stage liver disease-based Japan Integrated Scoring system may have a better predictive ability for patients with hepatocellular carcinoma undergoing locoregional therapy. Cancer. 2006;107:141-8.
Not in our library10.1002/cncr.21972
70.
Martins A, Cortez-Pinto H, Marques-Vidal P, et al. Treatment and prognostic factors in patients with hepatocellular carcinoma. Liver Int. 2006;26:680-7.
Not in our library10.1111/j.1478-3231.2006.001285.x
71.
Pascual S, Zapater P, Such J, et al. Comparison of staging systems to predict survival in hepatocellular carcinoma. Liver Int. 2006;26:673-9.
Not in our library10.1111/j.1478-3231.2006.01282.x
72.
Pignata S, Gallo C, Daniele B, et al. Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP). Crit Rev Oncol Hematol. 2006;59:243-9.
Not in our library10.1016/j.critrevonc.2006.01.002
73.
Tsukioka G, Kakizaki S, Sohara N, et al. Hepatocellular carcinoma in extremely elderly patients: an analysis of clinical characteristics, prognosis and patient survival. World J Gastroenterol. 2006;12:48-53.
Not in our library10.3748/wjg.v12.i1.48
74.
Yeo W, Mo FK, Koh J, et al. Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma. Ann Oncol. 2006;17:1083-9.
Not in our library10.1093/annonc/mdl065
75.
Huo TI, Huang YH, Chiang JH, et al. Survival impact of delayed treatment in patients with hepatocellular carcinoma undergoing locoregional therapy: is there a lead-time bias? Scand J Gastroenterol. 2007;42:485-92.
Not in our library10.1080/00365520600931402
76.
Nagaoka S, Yoshida T, Akiyoshi J, et al. Serum C-reactive protein levels predict survival in hepatocellular carcinoma. Liver Int. 2007;27:1091-7.
Not in our library10.1111/j.1478-3231.2007.01550.x
77.
Perry JF, Charlton B, Koorey DJ, et al. Outcome of patients with hepatocellular carcinoma referred to a tertiary centre with availability of multiple treatment options including cadaveric liver transplantation. Liver Int. 2007;27:1240-8.
Not in our library10.1111/j.1478-3231.2007.01569.x
78.
Tangkijvanich P, Thong-Ngam D, Mahachai V, Theamboonlers A, Poovorawan Y. Role of serum interleukin-18 as a prognostic factor in patients with hepatocellular carcinoma. World J Gastroenterol. 2007;13:4345-9.
Not in our library10.3748/wjg.v13.i32.4345
79.
Tangkijvanich P, Hourpai N, Rattanatanyong P, et al. Serum LINE-1 hypomethylation as a potential prognostic marker for hepatocellular carcinoma. Clin Chim Acta. 2007;379:127-33.
Not in our library10.1016/j.cca.2006.12.029
80.
Liaw YF, Tai DI, Chu CM, et al. Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study. Gastroenterology. 1986;90:263-7.
Not in our library10.1016/0016-5085(86)90919-4
81.
Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol. 2001;35:421-30.
Not in our library10.1016/s0168-8278(01)00130-1
82.
Poynard T, Aubert A, Lazizi Y, et al. Independent risk factors for hepatocellular carcinoma in French drinkers. Hepatology. 1991;13:896-901.
Not in our library
83.
Bolondi L, Sofia S, Siringo S, et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut. 2001;48:251-9.
Not in our library10.1136/gut.48.2.251
84.
Melia WM, Wilkinson ML, Portmann BC, Johnson PJ, Williams R. Hepatocellular carcinoma in the non-cirrhotic liver: a comparison with that complicating cirrhosis. Q J Med. 1984;53:391-400.
Not in our library
85.
Garcia-Tsao G, Bosch J, Groszmann RJ. Portal hypertension and variceal bleeding-unresolved issues. Summary of an American Association for the Study of Liver Diseases and European Association for the Study of the Liver Single Topic Conference. Hepatology. 2008;47:1764-72.
Not in our library10.1002/hep.22273
86.
Bruix J, Castells A, Bosch J, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology. 1996;111:1018-22.
Not in our library10.1016/s0016-5085(96)70070-7
87.
Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999;30:1434-40.
Not in our library10.1002/hep.510300629
88.
Huo TI, Huang YH, Lui WY, et al. Selective prognostic impact of serum alpha-fetoprotein level in patients with hepatocellular carcinoma: analysis of 543 patients in a single center. Oncol Rep. 2004;11:543-50.
Not in our library
89.
Farinati F, Marino D, De Giorgio M, et al. Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither? Am J Gastroenterol. 2006;101:524-32.
Not in our library10.1111/j.1572-0241.2006.00443.x

Cited by papers we hold 3

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.